sub-analysis (n = 100) found that median sCD40L and visfatin levels were higher in women with genotypes AT+TT (rs9939609) as compared to AA (1178 vs. 937.0 pg/mL and 0.93 vs. 0.43 ng/mL, respectively, p < 0.05). Conclusion Two SNP genotypes related to obesity were more prevalent in women with abnormal triglyceride levels and two vascular and inflammatory serum markers were higher in relation to the rs9939609 SNP.
Introduction
Menopause is associated with weight gain, especially due to visceral fat accumulation, increasing the prevalence of the metabolic syndrome (METS) and that of other co-morbid conditions, which enhance a pro-inflammatory status and consequently cardiovascular risk [1] [2] [3] [4] . The METS is a cluster of interdependent factors, including insulin resistance, abdominal adiposity, dyslipidemia and hypertension. Its prevalence increases after the menopause due to the loss of the protective role of estrogens and the dominance of circulating androgens, resulting in changes in fat distribution and body composition [1, 2] . After the menopause, increase in body weight worsens insulin resistance and enhances fat adipocytokine secretion. In this sense, we have previously reported on vascular, inflammatory and metabolic marker levels in postmenopausal women with and without the METS [5] . In this study, those with abdominal obesity displayed higher serum levels of adipsin, leptin and resistin together with lower adiponectin levels [5] . In the same population, serum IL-6 levels were higher among women with
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Objective To determine the prevalence of three single nucleotide polymorphisms (SNPs) in postmenopausal women with and without the metabolic syndrome (METS) and to explore levels of circulating biomarkers of inflammation, vascular and metabolic dysfunction according to SNP genotypes. Methods DNA was extracted from the whole blood of 192 natural postmenopausal women (40 to 65 years) screened for the METS and tested for three gene SNPs related to obesity: the fat mass obesity (FTO: rs9939609) and the methylenetetrahydrofolate reductase (MTHFR: C677T and A1298C). Blood levels of angiopoietin, IL-8, sFASL, IL-6, TNF-α, sCD40L, PAI-1, u-PA, leptin, adiponectin, resistin, ghrelin, visfatin, adipsin and insulin were measured in a subgroup, with and without the METS, using multiplex technology (n = 100) and compared according to SNP genotypes. Results Genotype frequency of the three studied SNPs did not differ in relation to the presence of the METS. However, genotypes CT+TT (C677T) and AT (rs9939609) were more prevalent in women with high triglyceride levels. Pooled abdominal obesity and low HDL-C and high tryglyceride levels. In addition, those with high glucose and low HDL-C levels displayed significantly higher sCD40L levels [6] . Our findings support a pro-inflammatory status in women with the METS and it components, especially abdominal obesity.
Abdominal obesity is a central component of the METS [7] . Gene mutations and single-nucleotide polymorphisms (SNPs) have been associated with obesity risk and insulin resistance. Indeed, reports highlight the importance of the fat mass and obesity (FTO) gene and its related SNPs, on obesity risk with gender differences observed [8] [9] [10] . On the other hand, SNPs related to the methylenetetrahydrofolate reductase (MTHFR) gene may also have an important role in the pathophysiology of insulin resistance and diabetes, conditions related to obesity [11, 12] . A systematic review found evidence of the association of the METS with eight SNPs, mostly located in genes involved in lipid metabolism [8] . Bearing the aforementioned in mind, and based on our previous findings, we further sought to determine the prevalence of three gene SNPs related to obesity and folate metabolism in postmenopausal women of a previous cohort screened for the METS and to explore circulating levels of markers of vascular, inflammatory and metabolic dysfunction, according to SNP genotypes. These SNPs were rs9939609 (for the FTO gene), and C677T and A1298C (for the MTHFR gene).
Materials and methods

Study design and participants
From December 2011 to June 2012 a cross-sectional study was carried out at the Instituto de Biomedicina of the Facultad de Ciencias Médicas, Universidad Católica de Santiago de Guayaquil, Guayaquil, Ecuador. The METS and its components were screened among natural postmenopausal women (40-65 years), recruited through newspaper advertising, who were not taking hormone therapy (HT), phytoestrogens or drugs intended to decrease lipid levels. After being informed about the study and requested to provide written consent of participation, eligible women were asked to return after an 8 h overnight fast, moment in which socio-demographic data, waist circumference (cm), weight (kg), height (m) and blood pressure (mmHg) measurements were recorded. In addition, a 10-15 mL peripheral venous blood sample was obtained to measure biochemical parameters (n = 192) and other specific vascular, inflammatory and metabolic markers (n = 100). As a secondary aim, this document analyzed the prevalence of three SNPs related to obesity and folate metabolism. The research protocol of the study was reviewed and approved by the Scientific Research Committee of the Institute of Biomedicine.
METS diagnostic criteria
The METS was defined using diagnostic criteria recommended by the American Heart Association and the National Heart, Lung, and Blood Institute [13] . This was the case if three or more of five criteria were encountered: abdominal obesity (waist circumference >88 cm), increased triglycerides (≥150 mg/dL), decreased HDL-C (<50 mg/dL), high fasting glucose levels (≥100 mg/dL) and/or increased blood pressure (≥130/85 mmHg). Women taking oral hypoglycemic or antihypertensive medication were considered, respectively, as diabetic or hypertense independent of the serum or blood pressure findings.
Single nucleotide polymorphism (SNP) genotyping
DNA was extracted from whole blood using the PureLink genomic kit (Invitrogen ® , Carlsbad, CA, USA), which was then amplified through conventional Polymerase Chain Reaction (PCR) technique using the following primers: 5′TGAAGGAGAAGGTGTCTGCGGGA3′ and 5′AGGACGGTGCGGTGAGAGTG3′ for C677T; 5′TGATGAAATCGGCTCCCGCA3′ and 5′TGATGATGA AATCGACTCCCGCA3′ for A1298C; and 5′TTGCGACT GCTGTGAATTTT3′, 5′TTGCGACTGCTGTGAATTTA3′ and 5′ATGGCTTCAGGGTACCAG3′ for rs9939609. Amplified products were used for the genotyping of each polymorphism using restriction fragment length polymorphism PCR (RFLP-PCR) for C677T and A1298C and conventional PCR for rs9939609.
Measurement of the different analytes
Blood samples withdrawn from each participant were centrifuged at 5 °C for 10 min at 3000 rpm. The obtained serum was treated accordingly to manufacturer instructions, decanted into 0.5 mL aliquots and then stored at −70 °C. Triglyceride (TG), HDL-C and glucose levels were assayed using the enzymatic colorimetric method with a Hitachi 717 automatic photometric analyzer (Roche Diagnostics GmbH, Mannheim, Germany).
As previously described [5, 14] , angiopoietin, IL-8, sFASL, IL-6, TNF-α, sCD40L, PAI-1, u-PA, leptin, adiponectin, resistin, ghrelin, visfatin, adipsin and insulin concentrations serum levels were measured (n = 100) using the Bio-Plex 200 System ® (Bio-Rad Laboratories, Inc, CA, USA; at the Bioclarma srl, Turin, Italy) [15] . All analytes are expressed as pg/mL except for adipsin (µg/mL), leptin (ng/mL), resistin (ng/mL), adiponectin (µg/mL), visfatin (ng/mL) and insulin (mUI/L).
Statistical analysis was performed using the Statistical Package for the Social Sciences version 21.0 (IBM SPSS, Armonk, NY, USA). Data are presented as medians [interquartile ranges: IQR], frequencies, percentages, odds ratios (OR) and 95 % confidence intervals (CI). The Kolmogorov-Smirnov test was used to determine the normality of data distribution. In accordance to this, the MannWhitney U test was used to analyze group differences (continuous data). The Chi-square test was used to compare percentages. For all calculations a p value of <0.05 was considered as statistically significant.
Results
Socio-demographic data and components of the METS among participants are presented in Table 1 . Age and time since menopause onset were similar between women with (n = 103) or without (n = 89) the METS; however, the frequency of the components of the METS were higher in those presenting the syndrome (Table 1) . Genotype frequency of the three studied SNPs did not differ in either groups (METS vs. non METS) ( Table 2 ). However, genotypes CT+TT (C677T) and AT (rs9939609) were more prevalent in women with high triglyceride levels. CT+TT and CT (C677T) genotypes were less prevalent in those with hyperglycemia.
Markers of vascular, inflammatory and metabolic dysfunction were measured in a subgroup of women with and without the METS (n = 100). This pooled analysis found that of all studied analytes, only sCD40L and visfatin levels were found higher in those with genotypes AT+TT Table 3) . No differences were found in levels of these analytes when women with normal vs. abnormal TG levels were compared.
Discussion
The METS is a cluster of features highly prevalent in postmenopausal women and related to obesity, insulin resistance, hyperinsulinemia and genetic factors. We previously reported evidence that postmenopausal women with the METS present a pro-inflammatory status related to obesity and abnormal secretion of adipocytokines and metabolic markers [5, 6] . Bearing this in mind, we sought to further explore candidate genes (FTO and MTHFR) for SNPs related to obesity and folate or homocysteine metabolism, aspects that are linked to cardiovascular risk.
SNPs of the FTO gene have been associated with obesity, although with ethnic differences. FTO genetic variants are associated (with low penetrance) to the obese phenotype in populations with European and Hispanic ancestry [16] [17] [18] . FTO variants are also related with obesity and type 2 diabetes in women with polycystic ovary syndrome (PCOS) [19] [20] [21] . A meta-analysis has reported that FTO SNPs are two times more prevalent in obese PCOS women than in the general population [22] and that in these women genetic background is associated with weight gain, abdominal adiposity and insulin resistance [23] . In our postmenopausal sample, FTO genotype variants did not differ in relation to the presence of the METS, abdominal obesity or glucose abnormality. Contrary to this, previous studies have demonstrated the influential role of the FTO gene in glucose intolerance (a component of the METS) of European women with PCOS but not in those without PCOS [24, 25] .
MTHFR gene polymorphisms have also been related to body mass index, the METS components and organ damage related to hypertension [26] [27] [28] [29] [30] . MTHFR regulates the 39] production of S-adenosyl methionine, which is the source of the methyl group that allows DNA methylation [31] . As with FTO, genotype frequency of analyzed MTHFR gene polymorphisms did not differ in accordance to the presence or not of the METS or of abdominal obesity. Nevertheless, prevalence of genotypes CT+TT (for the C677T SNP) and AT (for the rs9939609 SNP) were higher in women with high triglyceride levels, independent of presenting or not the METS. CT+TT and CT (C677T) genotypes were less frequent in those with hyperglycemia. Although these associations have not been reported in the literature, the possible clinical relevance needs to be further explored. In addition, and as already mentioned, the reported ethnic variation in the association between these SNPs and clinical parameters should be taken into account when analyzing results [32] , and they make comparisons between populations quite difficult.
In relation to the studied biomarkers, of all analytes only higher blood sCD40L and visfatin levels were found in women with genotypes AT+TT (rs9939609) as compared to AA. The sCD40L seems to play a significant role in vascular disease, endothelial dysfunction, thrombosis and inflammation, and is a marker of cardiovascular risk [33] [34] [35] . One study found associations between the rs9939609 SNP of the FTO gene and serum visfatin and abdominal fat in neonates [36] . Another reported a possible relation between visfatin gene expression in subcutaneous adipose tissue from patients with morbid obesity [37] . Visfatin is produced by visceral fat and its expression is increased in subjects with abdominal adiposity and type 2 diabetes [38] . However, circulating visfatin is not related with endpoints of insulin resistance such as fasting insulin and glucose levels [39] . There is no information regarding the associations we have found in postmenopausal women. Hence, there is a need for further research in this regard.
As for the limitations of the present study, cross-sectional design does not allow for determining causality, but only associations. Not determining homocysteine levels in order to perform correlations with SNP genotypes can also be seen as a potential limitation; however, resources for this study were limited. An ongoing study is analyzing midaged women (pre, peri and postmenopausal ones) including new biomarkers (i.e. homocysteine levels) and dietary and health life style changes to correlate functional changes in accordance to SNP genotype.
Despite the aforementioned limitations our data add to the scanty information analyzing the prevalence of obese related SNPs in postmenopausal women and also correlating SNP genotypes with vascular, inflammatory and metabolic markers. The present study found that two SNP genotypes (C677T of the MTHFR and the other of the FTO gene) were more prevalent in women with abnormal triglyceride levels and two vascular and inflammatory serum markers varied based on SNP genotype status (rs9939609 of the FTO gene). These results expand our knowledge regarding the relationship between the presence of specific genetic variants of metabolic-related genes and biochemical markers of inflammation, vascular and metabolic dysfunction in postmenopausal women with or without the METS. 
